Alternatively, albumin–bilirubin–based indices, including ALBI, EZ-ALBI, and PALBI, may be applied according to the clinician’s experience and preference, as these indices have demonstrated comparable prognostic performance in AD of cirrhosis, despite originally being developed for hepatocellular carcinoma prognosis [10–15,26]. Here, ALB is linked to Alzheimer disease.